Expression of a Siglec-Fc Protein and Its Characterization
The emerging importance of the Siglec-sialic acid axis in human disease, especially cancer, has necessitated the identification of ligands for Siglecs. Recombinant Siglec-Fc fusion proteins have been widely used as ligand detectors, and also as sialic acid-targeted antibody-like proteins for cancer...
Main Authors: | Kaijun Chi, Huilin Xu, Hanjie Li, Ganglong Yang, Xiaoman Zhou, Xiao-Dong Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/12/4/574 |
Similar Items
-
Siglecs as Therapeutic Targets in Cancer
by: Jackwee Lim, et al.
Published: (2021-11-01) -
Current Status on Therapeutic Molecules Targeting Siglec Receptors
by: María Pia Lenza, et al.
Published: (2020-12-01) -
Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases
by: Jannis Wißfeld, et al.
Published: (2024-03-01) -
Siglecs-mediated immune regulation in neurological disorders
by: Huifang Tu, et al.
Published: (2024-12-01) -
Hypersialylation and multiple myeloma
by: Michael O’Dwyer, et al.
Published: (2024-02-01)